21 peer-reviewed studies. 8,857 participants in clinical trials. Every ingredient in the formula traces back to public, citable research - the same studies you’d find in PubMed.

We don’t hide our sources behind “clinically studied” marketing copy. The full bibliography is below with author, journal, year, sample size where applicable, PMID, and a one-line finding. Click any entry for the PubMed abstract.

1. [1]Hallen A, Jarstrand C, Pahlson C (1992). Treatment of bacterial vaginosis with lactobacilli. Sexually Transmitted Diseases. PMID1523530.

   Ingredient:L. acidophilus

   57% of women treated with L. acidophilus had normal vaginal flora restored vs 0% placebo.

2. [2]Reznichenko H, et al. (2020). Oral Intake of Lactobacilli Can Be Helpful in Symptomatic Bacterial Vaginosis: A Randomized Clinical Study. Journal of Lower Genital Tract Disease. PMID32091443.

   Ingredient:L. acidophilus (combo)

   BV recurrence 18.3% vs 32.1% placebo (p=.014) in 166-woman trial.

3. [3]Reid G, et al. (2003). Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora. FEMS Immunology & Medical Microbiology. PMID12628548.

   Ingredient:L. rhamnosus

   37% on probiotics restored normal flora vs 13% placebo over 60 days.

4. [4]Cianci A, et al. (2008). Efficacy of L. rhamnosus GR-1 and L. reuteri RC-14 in the treatment and prevention of vaginoses and bacterial vaginitis relapses. Minerva Ginecologica. PMID18854803.

   Ingredient:L. rhamnosus + L. reuteri

   92% of patients achieved complete Lactobacilli recolonization.

5. [5]Ansari A, et al. (2023). Lactobacillus Probiotics Improve Vaginal Dysbiosis in Asymptomatic Women. Nutrients. PMID37111086.

   Ingredient:L. acidophilus + L. rhamnosus + L. reuteri

   60% of women with high Nugent scores improved to healthy after 6 weeks oral probiotic.

6. [6]Kohler GA, et al. (2012). Probiotic interference of L. rhamnosus GR-1 and L. reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infectious Diseases in Obstetrics & Gynecology. PMID22811591.

   Ingredient:L. rhamnosus + L. reuteri vs Candida

   Lactic acid suppressed C. albicans growth; reduced fluconazole-resistance gene expression (in vitro).

7. [7]De Seta F, et al. (2014). Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study. European Journal of Obstetrics, Gynecology and Reproductive Biology. PMID25305660.

   Ingredient:L. plantarum

   L. plantarum increased vaginal Lactobacillus levels in 89-woman 3-month study.

8. [8]De Seta F, et al. (2024). Efficacy and safety of Lactobacillus plantarum P 17630 strain soft vaginal capsules compared to antifungal treatment. Journal of Lower Genital Tract Disease. PMID38235890.

   Ingredient:L. plantarum vs antifungal

   L. plantarum non-inferior to standard antifungal for vaginal candidiasis.

9. [9]Spaggiari L, et al. (2024). Bacillus coagulans LMG S-24828 Impairs Candida Virulence and Protects Vaginal Epithelial Cells against Candida Infection In Vitro. Microorganisms. PMID39203476.

   Ingredient:B. coagulans vs Candida

   B. coagulans impaired Candida virulence and protected vaginal epithelium (in vitro).

10. [10]Tsimaris P, et al. (2020). Alleviation of vulvovaginitis symptoms: can probiotics lead the treatment plan?. Beneficial Microbes. PMID31965832.

    Ingredient:B. coagulans

    Significant reduction in vaginal pH + alleviation of vulvovaginal discomfort symptoms (p<0.001) in 70-woman trial.

11. [11]Williams G, et al. (2023). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. PMID37068952.

    Ingredient:Cranberry

    Cochrane Review of 50 studies (N=8,857) - cranberry products reduce UTI risk in women with recurrent UTIs.

12. [12]Fu Z, et al. (2017). Cranberry Reduces the Risk of Urinary Tract Infection Recurrence in Otherwise Healthy Women. Journal of Nutrition. PMID29046404.

    Ingredient:Cranberry

    Cranberry effective in preventing UTI recurrence in healthy women.

13. [13]Xiong Z, et al. (2024). Preventive effect of cranberries with high dose of proanthocyanidins on UTI: a meta-analysis. Frontiers in Nutrition. PMID39668896.

    Ingredient:Cranberry PAC dose

    Higher proanthocyanidin doses correlate with stronger UTI prevention effect.

14. [14]Kranjcec B, et al. (2014). D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World Journal of Urology. PMID23633128.

    Ingredient:D-Mannose

    Recurrence dropped from 60.8% (no prophylaxis) to 14.6% on D-mannose, comparable to nitrofurantoin (20.4%) - N=308.

15. [15]Lenger SM, et al. (2020). D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. American Journal of Obstetrics & Gynecology. PMID32497610.

    Ingredient:D-Mannose

    D-mannose appears protective vs placebo; possibly similar effectiveness as antibiotics.

16. [16]Jadhav A, et al. (2017). The Dietary Food Components Capric Acid and Caprylic Acid Inhibit Virulence Factors in Candida albicans Through Multitargeting. Journal of Medicinal Food. PMID28922057.

    Ingredient:Caprylic acid vs Candida

    Caprylic acid inhibits morphogenesis, adhesion, biofilm formation, and arrests Candida cell cycle.

17. [17]Kim SH, et al. (2007). Inhibition of Candida mycelia growth by caprylic acid and capric acid. Journal of Microbiology & Biotechnology. PMID23257726.

    Ingredient:Caprylic acid antifungal

    Caprylic acid inhibits Candida mycelia growth at low concentrations.

18. [18]Kim SH, et al. (2019). Short-Term Antifungal Treatments of Caprylic Acid with Carvacrol or Thymol Synergistically Inhibit Candida albicans. mSphere. PMID31334617.

    Ingredient:Caprylic + carvacrol synergy

    Caprylic acid + carvacrol show synergistic antifungal effect - Balance Complex uniquely combines both.

19. [19]Chami F, et al. (2004). Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat model. Journal of Antimicrobial Chemotherapy. PMID15456732.

    Ingredient:Carvacrol (oregano) vaginal

    Carvacrol eradicated vaginal fungal burden in 7/9 rats (prophylactic in vivo).

20. [20]Kelly GS (1999). Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide. Alternative Medicine Review. PMID10231609.

    Ingredient:Arabinogalactan

    Arabinogalactan enhances Lactobacillus + Bifidobacteria; FDA-approved dietary fiber.

21. [21]Henao SLD, et al. (2018). Randomized Clinical Trial for the Evaluation of Immune Modulation by β-Glucans from Ganoderma lucidum. International Journal of Medicinal Mushrooms. PMID30317947.

    Ingredient:Reishi (Ganoderma lucidum)

    Significantly increased peripheral blood lymphocyte counts vs placebo (RCT).

Two additional supporting references (Aloe vera + Black walnut hulls) are cited as “in published research” in the formula breakdown without a specific PMID - full bibliography entries pending vault verification.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.